IPO
📈 Stocks
ADARx Targets $1.74 Billion Valuation in Upcoming Nasdaq IPO
(50 days ago)
ADARx Pharmaceuticals eyes a $1.74 billion valuation as it joins a wave of biotech listings, supported by a strategic $100 million investment…